GEN Exclusives

More »

GEN News Highlights

More »
Dec 6, 2006

Bayer Licenses Brenda-Amenda Database for Target Research

  • Bayer HealthCare gained access to Biobase’s enzyme and metabolism research database, according to a license agreement between the two companies. The Brenda-Amenda database summarizes more than 50 years worth of research in this field. Bayer Healthcare will be using the database for target-based research related to cardiovascular disease.

    The new text-mining based Amenda module expands Brenda's enzyme-related reference content five-fold by means of structured access to organism-specific enzyme information, such as statements about tissue affiliation or subcellular localization, from 15 million PubMed articles.

    Brenda-Amenda is a relational database that contains manually-curated biochemical and molecular information about more than 83,000 enzymes from 9,800 organisms. To date, Brenda-Amenda contains 500,000 enzyme-ligand correlations, including more than 46,000 different chemical compounds that act as ligands and 34,500 ligand structures.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?